United Kingdom

People: Lantheus Holdings Inc (LNTH.OQ)

LNTH.OQ on NASDAQ Stock Exchange Global Market

23 Aug 2019
Change (% chg)

$-0.86 (-3.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Heino, Mary 

Ms. Mary Anne Heino is the President, Chief Executive Officer, Director of Lantheus Holdings Inc. Ms. Heino has served as our President and Chief Executive Officer and as a Director since August 2015. She previously served as our Chief Operating Officer, a position she held from March 2015 until August 2015, and as our Chief Commercial Officer, a position she held from April 2013 (when she joined the Company) until March 2015. Ms. Heino brings 30 years of diverse pharmaceutical industry experience to the Board. Prior to joining Lantheus, Ms. Heino led Angelini Labopharm LLC and Labopharm USA in the roles of President and Senior Vice President of World Wide Sales and Marketing from February 2007 to March 2012. From May 2000 until February 2007, Ms. Heino served in numerous capacities at Centocor, Inc., a J&J company, including as Vice President, Strategic Planning and Competitive Intelligence, Vice President, Sales, Executive Director, Customer Relationship Management and Senior Director, Immunology Marketing. Ms. Heino began her professional career with Janssen Pharmaceutica as a Sales Representative in June 1989 and worked her way up to the role of Field Sales Director in 1999. Ms. Heino received her Master in Business Administration from the Stern School of Business at New York University. She earned a Bachelor of Science in Nursing from the City University of New York and a Bachelor of Science in Biology from the State University of New York at Stony Brook. Ms. Heino was chosen as a Director because of her role as President and Chief Executive Officer, which gives her an extensive understanding of our business and operations, and because of her strong commercial experience in the pharmaceutical industry.

Basic Compensation

Total Annual Compensation, USD 665,577
Restricted Stock Award, USD 2,318,480
Long-Term Incentive Plans, USD --
All Other, USD 929,875
Fiscal Year Total, USD 3,913,930

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Brian Markison


Mary Heino


Robert Marshall


John Bolla


Michael Duffy


Sarah Roy

As Of  31 Dec 2018